Paloma Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,700
Closed -$1.49M 2365
2019
Q3
$1.49M Buy
+13,700
New +$1.43M 0.03% 558
2018
Q2
Sell
-31,200
Closed -$2.5M 1984
2018
Q1
$2.5M Buy
31,200
+3,200
+11% +$264K 0.04% 456
2017
Q4
$2.26M Sell
28,000
-21,500
-43% -$1.72M 0.03% 616
2017
Q3
$3.85M Buy
49,500
+21,500
+77% +$1.79M 0.05% 372
2017
Q2
$2.48M Buy
+28,000
New +$2.36M 0.03% 621

Other funds holding MDT

Paloma Partners's MDT Position: Q2 2025 in Review

Paloma Partners sold out of Medtronic (MDT) in Q2 2025, closing a stake of 10,156 shares — an estimated $913K sold.

Paloma Partners first reported a position in MDT in Q3 2013 and held it in 26 quarters. The position peaked at $18.4M in Q4 2021. 2,145 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Paloma Partners reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • Paloma Partners sold 10,156 Medtronic shares in Q2 2025, an estimated $913K.
  • Paloma Partners first reported a position in Medtronic in Q3 2013 and held it in 26 quarters.
  • Paloma Partners's Medtronic position peaked at $18.4M in Q4 2021.
  • 2,145 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Paloma Partners's 13F filing for Q2 2025, filed 14 Aug 2025.